Intensity Modulated Radiation Therapy (IMRT) followed by Cesium-131 Brachytherapy for Intermediate and High Risk Localized Prostate Cancer

This study intends to explore biochemical success and morbidity profiles in an elevated risk cohort of men treated with IMRT and Cesium-131 brachytherapy boost. For this study the Cs-131 boost was reduced from a typical 85 Gy implant to 70 Gy: it is hypothesized that this combination of IMRT and brachytherapy will Result in favorable disease control alone with an acceptable morbidity profile.

Source: Brachytherapy - April 30, 2019 Category: Cancer & Oncology Authors: John Sylvester, Michelle H. Braccioforte, Brian J. Moran Source Type: research